Exact Sciences helps health systems change the way cancer is detected and treated.
![group-800](/-/media/project/exactcore/healthsystems/images/promo/mask-group.png?rev=c4c2fb387eec4f0eba2c108b00c39102)
Lasting change is accelerated by collaboration. Together we can change the future of cancer care.
Exact Sciences is:
- Dedicated to eradicating cancer and the suffering it causes through tests that help detect cancer, assess cancer risk, and guide treatment
- A trusted advisor for health systems in serving newly diagnosed and advanced-stage cancer patients through our expanding product portfolio
- A supplier of timely genomic tools and technology backed by rigorous clinical evidence and remarkable service at every step
![group-876](/-/media/project/exactcore/healthsystems/images/promo/mask-group-1.png?rev=25a7db45d01343f09d00daefaffb2f13)
Our commitment to supporting health systems and cancer patients is simple:
- Broaden clinician and patient access to best practices in early detection and intervention
- Streamline precision medicine workflow with actionable genomic information and technology
- Offer tests that deliver insights that can help providers align patients with the latest therapies and clinical trials
Enabling, empowering, and advancing cancer care
The Cologuard test has been reviewed and approved by the FDA as an In Vitro Diagnostic (IVD). All other on- market tests listed were developed, and the performance characteristics validated by an Exact Sciences clinical laboratory following College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) regulations. These tests have not been cleared or approved by the US Food and Drug Administration.